Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Bazin

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
ACS Omega|October 2, 2019
Synthetic Toll-like Receptors 7 and 8 Agonists: Structure-Activity Relationship in the Oxoadenine SeriesJay T Evans, Laura S Bess, Sandra C Mwakwari, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2020
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activityHélène G Bazin, Laura S Bess, Mark T Livesay, et al.
NPJ Vaccines|July 10, 2023
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in miceShannon M Miller, Bethany Crouse, Linda Hicks, et al.
Frontiers in Immunology|March 27, 2020
Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in MiceShannon M Miller, Van Cybulski, Margaret Whitacre, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2015
Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chainsJuhienah K Khalaf, William S Bowen, Hélène G Bazin, et al.
Pharmaceutics|January 23, 2024
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune ResponsesWalid M Abdelwahab, Sarah Auclair, Timothy Borgogna, et al.
Frontiers in Immunology|August 7, 2024
Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitizationKonner J Jackson, Cassandra Buhl, Shannon M Miller, et al.
Journal of Medicinal Chemistry|October 17, 2023
Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 AgonistsJuhienah K Khalaf, Laura S Bess, Lois M Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimeticsHélène G Bazin, Tim J Murray, William S Bowen, et al.
Scientific Reports|October 18, 2022
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccinationDavid J Dowling, Soumik Barman, Alyson J Smith, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
ACS Omega|October 2, 2019
Synthetic Toll-like Receptors 7 and 8 Agonists: Structure-Activity Relationship in the Oxoadenine SeriesJay T Evans, Laura S Bess, Sandra C Mwakwari, et al.
Bioorganic & Medicinal Chemistry Letters|February 1, 2020
Optimization of 8-oxoadenines with toll-like-receptor 7 and 8 activityHélène G Bazin, Laura S Bess, Mark T Livesay, et al.
NPJ Vaccines|July 10, 2023
A lipidated TLR7/8 adjuvant enhances the efficacy of a vaccine against fentanyl in miceShannon M Miller, Bethany Crouse, Linda Hicks, et al.
Frontiers in Immunology|March 27, 2020
Novel Lipidated Imidazoquinoline TLR7/8 Adjuvants Elicit Influenza-Specific Th1 Immune Responses and Protect Against Heterologous H3N2 Influenza Challenge in MiceShannon M Miller, Van Cybulski, Margaret Whitacre, et al.
Bioorganic & Medicinal Chemistry Letters|January 3, 2015
Characterization of TRIF selectivity in the AGP class of lipid A mimetics: role of secondary lipid chainsJuhienah K Khalaf, William S Bowen, Hélène G Bazin, et al.
Pharmaceutics|January 23, 2024
Co-Delivery of a Novel Lipidated TLR7/8 Agonist and Hemagglutinin-Based Influenza Antigen Using Silica Nanoparticles Promotes Enhanced Immune ResponsesWalid M Abdelwahab, Sarah Auclair, Timothy Borgogna, et al.
Frontiers in Immunology|August 7, 2024
Intranasal administration of a synthetic TLR4 agonist INI-2004 significantly reduces allergy symptoms following therapeutic administration in a murine model of allergic sensitizationKonner J Jackson, Cassandra Buhl, Shannon M Miller, et al.
Journal of Medicinal Chemistry|October 17, 2023
Diamino Allose Phosphates: Novel, Potent, and Highly Stable Toll-like Receptor 4 AgonistsJuhienah K Khalaf, Laura S Bess, Lois M Walsh, et al.
Bioorganic & Medicinal Chemistry Letters|October 7, 2008
The 'Ethereal' nature of TLR4 agonism and antagonism in the AGP class of lipid A mimeticsHélène G Bazin, Tim J Murray, William S Bowen, et al.
Scientific Reports|October 18, 2022
Development of a TLR7/8 agonist adjuvant formulation to overcome early life hyporesponsiveness to DTaP vaccinationDavid J Dowling, Soumik Barman, Alyson J Smith, et al.
Pageof 3